1. Home
  2. GNT vs NYXH Comparison

GNT vs NYXH Comparison

Compare GNT & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GAMCO Natural Resources Gold & Income Trust

GNT

GAMCO Natural Resources Gold & Income Trust

HOLD

Current Price

$9.18

Market Cap

153.6M

Sector

Finance

ML Signal

HOLD

Logo Nyxoah SA

NYXH

Nyxoah SA

HOLD

Current Price

$1.63

Market Cap

161.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNT
NYXH
Founded
2011
2009
Country
United States
Belgium
Employees
N/A
N/A
Industry
Finance/Investors Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
153.6M
161.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
GNT
NYXH
Price
$9.18
$1.63
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$9.33
AVG Volume (30 Days)
77.3K
185.9K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
6.61%
N/A
EPS Growth
N/A
N/A
EPS
0.95
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$213.98
Revenue Next Year
N/A
$126.25
P/E Ratio
$9.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.68
$1.26
52 Week High
$9.38
$6.87

Technical Indicators

Market Signals
Indicator
GNT
NYXH
Relative Strength Index (RSI) 64.85 58.75
Support Level $7.81 $1.28
Resistance Level $9.26 $1.70
Average True Range (ATR) 0.14 0.07
MACD -0.01 0.00
Stochastic Oscillator 74.26 59.12

Price Performance

Historical Comparison
GNT
NYXH

About GNT GAMCO Natural Resources Gold & Income Trust

GAMCO Natural Resources, Gold & Income Trust is a non-diversified closed-end management investment company. The company's primary investment objective is to provide a high level of current income from interest, dividends, and options premiums with its secondary objective being capital appreciation. Under normal market conditions, the company invests majority of its assets in securities of companies principally engaged in the natural resources and gold industries, and also engages in writing covered call options on the underlying equity securities. Its portfolio consists of securities from different sectors such as metals and mining, energy and energy services, specialty chemicals, agriculture, healthcare, machinery, food and beverage, and others.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: